Cure My Disease

Don't miss your cure!

 Log in / Sign up

Eye surface disease study seeks to unlock vision predictors

NCT ID NCT07694817

Not yet recruiting Knowledge-focused Sponsor: IRCCS San Raffaele Source: ClinicalTrials.gov ↗

First seen Jul 10, 2026 · Last updated Jul 15, 2026 · Updated 2 times

Summary

This study aims to find which eye tests best predict vision in people with surface eye diseases like neurotrophic keratopathy and limbal stem cell deficiency. Researchers will collect data from standard exams and patient questionnaires from 1,000 adults. The goal is to identify key biomarkers for vision prognosis and improve personalized care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could help doctors better predict vision outcomes and tailor treatments for people with eye surface diseases.
What could go wrong
This is an observational study, so it won't test a new treatment. The findings may not apply to all patients or lead to immediate changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORNEA ABNORMALITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

corneal disorder exposure keratitis keratitis keratopathy limbal stem cell deficiency neurotrophic keratopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORNEA ABNORMALITY CORNEA DISEASE CORNEA INFLAMED EXPOSURE KERATOPATHY LIMBAL STEM CELL DEFICIENCY (LSCD) NEUROTROPHIC KERATOPATHY

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • IRCCS San Raffaele Scientific Institute

    Milan, 20132, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.